These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16858477)

  • 1. The use of botulinum toxin in the treatment of headaches.
    Mauskop A
    Pain Physician; 2004 Jul; 7(3):377-87. PubMed ID: 16858477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of botulinum toxin in the treatment of headaches.
    Mauskop A
    Curr Pain Headache Rep; 2002 Aug; 6(4):320-3. PubMed ID: 12095468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of headaches with botulinum toxin.
    Samton J; Mauskop A
    Expert Rev Neurother; 2006 Mar; 6(3):313-22. PubMed ID: 16533136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of botulinum toxin type A in the prophylactic treatment of migraine headaches.
    Chilson CN; Brown SJ
    Ann Pharmacother; 2005 Dec; 39(12):2081-5. PubMed ID: 16264063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the treatment of headaches.
    Evers S; Frese A
    Curr Opin Anaesthesiol; 2005 Oct; 18(5):563-8. PubMed ID: 16534293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin for the treatment of headache: a promising path on a "dead end road"?
    Delstanche S; Schoenen J
    Acta Neurol Belg; 2010 Sep; 110(3):221-9. PubMed ID: 21114129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prophylactic treatment of chronic daily headache.
    Mathew NT
    Headache; 2006; 46(10):1552-64. PubMed ID: 17115988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A for the treatment of nummular headache: four case studies.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2008 Mar; 48(3):442-7. PubMed ID: 18028377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evidence based guidelines for the treatment of primary headaches].
    Demarin V; Vuković V; Lovrencić-Huzjan A; Lusić I; Janculjak D; Wilheim K; Zurak N
    Acta Med Croatica; 2008 May; 62(2):99-136. PubMed ID: 18710075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effectiveness and safety of botulinum toxin in the treatment of chronic primary headaches].
    Volcy-Gómez M
    Rev Neurol; 2004 Aug 16-31; 39(4):388-93. PubMed ID: 15340901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
    Saper JR; Mathew NT; Loder EW; DeGryse R; VanDenburgh AM;
    Pain Med; 2007 Sep; 8(6):478-85. PubMed ID: 17716321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical trial comparing botulinum toxin injections with 0.2 per cent nitroglycerin ointment for chronic anal fissure.
    Brisinda G; Cadeddu F; Brandara F; Marniga G; Maria G
    Br J Surg; 2007 Feb; 94(2):162-7. PubMed ID: 17256809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A in chronic migraine.
    Freitag FG
    Expert Rev Neurother; 2007 May; 7(5):463-70. PubMed ID: 17492897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive migraine treatment.
    Silberstein SD
    Neurol Clin; 2009 May; 27(2):429-43. PubMed ID: 19289224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migraine in the managed care environment.
    Owens GM
    Am J Manag Care; 2005 Jun; 11(2 Suppl):S68-71. PubMed ID: 16095270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Botulinum Toxin Type A in Headache Treatment.
    Mathew NT; Kaup AO
    Curr Treat Options Neurol; 2002 Sep; 4(5):365-373. PubMed ID: 12162925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.